tiprankstipranks
Trending News
More News >
HOYA CORPORATION (JP:7741)
:7741
Advertisement

HOYA (7741) AI Stock Analysis

Compare
8 Followers

Top Page

JP:7741

HOYA

(7741)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
¥24,852.00
▲(7.54% Upside)
HOYA's overall stock score reflects strong financial performance, with robust profitability and a solid balance sheet. Technical analysis presents mixed signals, with short-term bearishness but longer-term bullish trends. The valuation suggests the stock may be overvalued, which slightly tempers the overall score. The absence of earnings call and corporate events data means these factors do not influence the score.
Positive Factors
Strong Balance Sheet
A low debt-to-equity ratio indicates minimal financial leverage and risk, providing HOYA with financial stability and flexibility for future investments.
Revenue Growth
Strong revenue growth reflects robust demand for HOYA's products, enhancing its market position and supporting long-term profitability.
Cash Generation
Efficient cash generation supports operational needs and strategic investments, ensuring HOYA's ability to sustain growth and manage financial obligations.
Negative Factors
Gross Profit Margin Decline
A declining gross profit margin may indicate rising costs or pricing pressures, which could impact profitability if not addressed.
Slowing Cash Flow Growth
Slowing cash flow growth could limit HOYA's ability to invest in new opportunities and maintain its competitive edge if the trend continues.
Valuation Concerns
High valuation may limit stock price appreciation potential and reflect investor expectations that could be challenging to meet.

HOYA (7741) vs. iShares MSCI Japan ETF (EWJ)

HOYA Business Overview & Revenue Model

Company DescriptionHOYA Corporation operates as a med-tech company, and a supplier of high-tech and medical products worldwide. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and medical related products, such as prosthetic ceramic fillers and metallic implants. It also operates Eyecity, a specialty retailer of contact lenses. In addition, the company provides information technology products, such as mask blanks and photomasks for manufacturing semiconductor chips; photomasks for liquid crystal display panels; glass disks for hard disk drives; and imaging products that include optical glasses/optical lenses, colored glass filters, and laser equipment/UV light resources. Further, it offers ReadSpeaker, a speech synthesis software; and cloud services comprising Kinnosuke that is a time and attendance management service, and Yonosuke, an electronic payslip service. HOYA Corporation was founded in 1941 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyHOYA generates revenue through multiple key streams. The Healthcare segment contributes significantly by selling intraocular lenses and surgical instruments for cataract surgery, as well as a variety of eyeglass lenses and contact lenses. Revenue in this sector is bolstered by ongoing demand for vision correction products and an aging population. The Electronics segment generates income by supplying photomasks and other critical materials used in semiconductor fabrication, catering to major tech companies in the electronics industry. Strategic partnerships with leading semiconductor manufacturers and healthcare providers enhance HOYA's market presence and revenue opportunities. Additionally, the company invests in research and development to innovate and expand its product offerings, further driving growth and profitability.

HOYA Financial Statement Overview

Summary
HOYA's financial performance is robust, characterized by strong profitability, a solid balance sheet, and healthy cash flows. The company exhibits impressive revenue growth and efficient operations, with minimal financial leverage. While the slight decline in gross profit margin and slowing cash flow growth warrant monitoring, the overall financial health remains strong, positioning HOYA well for future growth and stability.
Income Statement
85
Very Positive
HOYA demonstrates strong profitability with a high gross profit margin of 73.91% and a solid net profit margin of 23.34% in the TTM. The company has shown impressive revenue growth, particularly in the TTM with a 76.6% increase, indicating robust demand for its products. EBIT and EBITDA margins are also healthy, reflecting efficient operations. However, the slight decline in gross profit margin from the previous year suggests potential cost pressures.
Balance Sheet
88
Very Positive
HOYA maintains a strong balance sheet with a low debt-to-equity ratio of 0.038, indicating minimal leverage and financial risk. The return on equity is robust at 20.39%, showcasing effective use of shareholder funds to generate profits. The equity ratio is healthy, suggesting a stable financial structure. Overall, the balance sheet reflects financial stability and low risk.
Cash Flow
82
Very Positive
The cash flow statement reveals strong cash generation capabilities, with a free cash flow to net income ratio of 79.62% and a consistent operating cash flow coverage ratio. The free cash flow growth rate of 3.02% in the TTM indicates steady cash flow improvements. However, the growth rate has slowed compared to previous periods, which could be a point of concern if it continues.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue872.66B866.03B762.61B723.58B661.47B547.92B
Gross Profit700.53B693.58B606.30B567.05B511.05B424.21B
EBITDA313.89B309.48B284.45B266.20B254.48B196.57B
Net Income206.78B202.10B181.38B168.64B164.51B125.45B
Balance Sheet
Total Assets1.23T1.23T1.20T1.03T992.84B853.29B
Cash, Cash Equivalents and Short-Term Investments533.64B533.97B525.16B405.89B419.40B334.90B
Total Debt39.24B37.28B29.24B24.58B21.60B20.75B
Total Liabilities258.76B262.65B241.36B213.72B203.78B180.88B
Stockholders Equity976.83B974.02B967.76B818.32B803.85B688.00B
Cash Flow
Free Cash Flow192.85B187.19B181.73B168.36B161.18B120.57B
Operating Cash Flow242.94B235.11B222.80B201.83B190.06B151.81B
Investing Cash Flow-45.98B-35.82B-35.81B-39.93B-29.13B-29.79B
Financing Cash Flow-178.78B-187.72B-110.89B-202.16B-106.89B-115.67B

HOYA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price23110.00
Price Trends
50DMA
22555.80
Positive
100DMA
20549.98
Positive
200DMA
18888.54
Positive
Market Momentum
MACD
193.00
Positive
RSI
45.59
Neutral
STOCH
12.13
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7741, the sentiment is Positive. The current price of 23110 is below the 20-day moving average (MA) of 24213.50, above the 50-day MA of 22555.80, and above the 200-day MA of 18888.54, indicating a neutral trend. The MACD of 193.00 indicates Positive momentum. The RSI at 45.59 is Neutral, neither overbought nor oversold. The STOCH value of 12.13 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:7741.

HOYA Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
¥3.63T27.789.31%1.18%7.68%10.08%
72
Outperform
$2.13T19.2313.13%1.07%0.42%34.76%
68
Neutral
$8.61T41.3420.74%1.04%8.83%8.63%
68
Neutral
$667.11B52.3510.09%0.84%13.53%-7.39%
62
Neutral
¥242.85B22.304.38%2.03%6.04%733.13%
60
Neutral
$1.06T22.559.80%1.74%1.51%-12.59%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7741
HOYA
23,110.00
3,505.45
17.88%
JP:4543
Terumo
2,460.00
-614.78
-19.99%
JP:7747
Asahi Intecc Co
2,893.00
230.12
8.64%
JP:8086
Nipro
1,489.00
124.78
9.15%
JP:7733
Olympus
2,071.50
-346.79
-14.34%
JP:6869
Sysmex
1,558.50
-1,584.40
-50.41%

HOYA Corporate Events

HOYA Corporation to Restructure Contact Lens Business
Nov 5, 2025

HOYA Corporation announced a strategic move to transfer its contact lens retail business to a newly formed subsidiary, HOYA Eye Care Retailing Corporation, effective April 1, 2026. This decision aims to enhance business operations by allowing for more focused sales, marketing, and store management strategies tailored to the contact lens industry, potentially improving market positioning and operational efficiency.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen30000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Updates on Share Repurchase Progress
Nov 4, 2025

HOYA Corporation announced the status of its ongoing share repurchase plan, which was resolved by the Board of Directors in August 2025. As of October 31, 2025, the company repurchased 2,022,600 shares for approximately 44.56 billion yen, as part of a larger plan to buy back up to 6.2 million shares. This strategic move is likely to impact the company’s stock value and shareholder returns, reflecting HOYA’s commitment to enhancing shareholder value.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen30000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Reports Strong Quarterly Growth
Oct 31, 2025

HOYA Corporation is a diversified technology company primarily engaged in the production of health care and information technology products, including eyeglass lenses, medical equipment, and electronics-related products. In its latest earnings report, HOYA Corporation reported a robust performance for the quarter ending September 30, 2025, with a 9.2% increase in revenue to ¥234,494 million and a 14.5% rise in profit before tax to ¥71,930 million compared to the same period last year. The company’s Life Care and Information Technology segments both contributed to this growth, with notable increases in sales of eyeglass lenses and electronics-related products. The Life Care segment saw a 7.8% revenue growth, driven by strong sales in Europe and strategic acquisitions, while the Information Technology segment experienced an 11.9% increase, supported by high demand for semiconductor-related products. Looking ahead, HOYA Corporation remains cautiously optimistic, focusing on sustaining its growth momentum through strategic investments and market expansion, despite potential economic and currency exchange challenges.

HOYA Corporation Announces Significant Interim Dividend Increase
Oct 31, 2025

HOYA Corporation announced an interim dividend of 125 yen per share for the fiscal year ending March 31, 2026, marking a significant increase from the previous year’s interim dividend. This decision reflects HOYA’s strategy to enhance corporate value by balancing growth investments with shareholder returns, while maintaining financial soundness and capital efficiency.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen25911.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Transfers Voice Synthetic Software Business to Subsidiary
Sep 5, 2025

HOYA Corporation announced the transfer of its voice synthetic software business to its subsidiary, ReadSpeaker Japan Co., Ltd., through a simplified absorption-type company split. This strategic move aims to optimize the allocation of HOYA’s management resources and involves transferring shares to a special purpose company operated by Marunouchi Capital Inc., potentially impacting HOYA’s focus and resource distribution in its core business areas.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen22000.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Corporation Updates on Share Repurchase Plan
Sep 1, 2025

HOYA Corporation announced the status of its share repurchase plan, initially resolved at the Board of Directors meeting on August 21, 2025. The company repurchased 459,600 shares for approximately 8.8 billion yen between August 22 and August 31, 2025, as part of a broader plan to repurchase up to 6.2 million shares by January 2026. This move is likely aimed at enhancing shareholder value and optimizing capital structure, reflecting a strategic approach to maintaining its market position.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen23300.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA Completes Treasury Stock Disposal for Compensation Plans
Aug 25, 2025

HOYA Corporation has completed the payment procedures for the disposal of 8,700 shares of treasury stock as part of its Performance Based Stock Compensation (PSU) and Stock Compensation (RSU) plans. This move, resolved by the Board of Directors, reflects the company’s commitment to aligning executive and director compensation with performance, potentially impacting stakeholder perceptions and company operations positively.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen23300.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

HOYA CORPORATION Announces Share Repurchase Plan
Aug 21, 2025

HOYA CORPORATION has announced a decision to repurchase up to 6.2 million of its own shares, representing 1.81% of its total outstanding shares, as part of a strategy to enhance shareholder value, improve capital efficiency, and maintain a flexible capital policy. The repurchase, which will occur on the Tokyo Stock Exchange between August 22, 2025, and January 21, 2026, is intended to benefit shareholders and the purchased shares are planned to be cancelled.

The most recent analyst rating on (JP:7741) stock is a Buy with a Yen23300.00 price target. To see the full list of analyst forecasts on HOYA stock, see the JP:7741 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 21, 2025